BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
+11.62%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$1.17B
AUM Growth
+$1.17B
(+16%)
Cap. Flow
+$78.7M
Cap. Flow
% of AUM
6.71%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
149
New
25
Increased
54
Reduced
51
Closed
11
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$12.2M |
| 2 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
$12.1M |
| 3 |
Cigna
CI
|
$11.7M |
| 4 |
Viatris
VTRS
|
$9.7M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$8.05M |
Top Sells
| 1 |
Incyte
INCY
|
$11.8M |
| 2 |
UnitedHealth
UNH
|
$11.3M |
| 3 |
Align Technology
ALGN
|
$10.4M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.27M |
| 5 |
Integra LifeSciences
IART
|
$8.56M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Industrials | 0.76% |
| 3 | Technology | 0.15% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Qiagen
QGEN
$10.1B
| $2.78M | 0.24% |
+72,463
| New | +$2.78M |
|
77
Coherus Oncology, Inc. Common Stock
CHRS
$146M
| $2.77M | 0.24% |
197,835
+47,835
| +32% | +$670K |
|
|
QTNT
78
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $2.57M | 0.22% |
7,995
+5,245
| +191% | +$1.68M |
|
79
Tandem Diabetes Care
TNDM
$834M
| $2.51M | 0.21% |
+114,006
| New | +$2.51M |
|
80
Ligand Pharmaceuticals
LGND
$3.25B
| $2.5M | 0.21% |
19,348
-7,342
| -28% | -$949K |
|
|
EGRX
81
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $2.5M | 0.21% |
33,000
| – | – |
|
82
Agios Pharmaceuticals
AGIO
$2.36B
| $2.43M | 0.21% |
28,811
-11,489
| -29% | -$968K |
|
83
Johnson & Johnson
JNJ
$429B
| $2.43M | 0.21% |
20,000
| – | – |
|
84
Quanterix
QTRX
$202M
| $2.38M | 0.2% |
165,480
+81,680
| +97% | +$1.17M |
|
85
Teva Pharmaceuticals
TEVA
$21.5B
| $2.19M | 0.19% |
90,000
| – | – |
|
|
ICPT
86
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $2.07M | 0.18% |
24,648
-7,252
| -23% | -$608K |
|
|
NVRO
87
DELISTED
NEVRO CORP.
NVRO
| $2.06M | 0.18% |
25,798
+15,098
| +141% | +$1.21M |
|
|
BLUE
88
DELISTED
bluebird bio
BLUE
| $2.03M | 0.17% |
996
-31
| -3% | -$63K |
|
89
HCA Healthcare
HCA
$95.4B
| $1.95M | 0.17% |
19,000
-2,300
| -11% | -$236K |
|
90
Penumbra
PEN
$10.5B
| $1.94M | 0.17% |
14,027
-2,773
| -17% | -$383K |
|
|
SAGE
91
DELISTED
Sage Therapeutics
SAGE
| $1.89M | 0.16% |
12,100
-350
| -3% | -$54.8K |
|
|
ONC
92
BeOne Medicines Ltd. American Depositary Shares
ONC
$37B
| $1.77M | 0.15% |
11,500
-29,150
| -72% | -$4.48M |
|
93
Inspire Medical Systems
INSP
$2.53B
| $1.71M | 0.15% |
+47,953
| New | +$1.71M |
|
94
Regenxbio
RGNX
$498M
| $1.71M | 0.15% |
+23,800
| New | +$1.71M |
|
95
Nektar Therapeutics
NKTR
$543M
| $1.69M | 0.14% |
2,300
-67
| -3% | -$49.1K |
|
96
AngioDynamics
ANGO
$432M
| $1.68M | 0.14% |
75,700
-26,000
| -26% | -$578K |
|
|
AGN
97
DELISTED
Allergan plc
AGN
| $1.67M | 0.14% |
10,000
-3,000
| -23% | -$500K |
|
98
McKesson
MCK
$85.9B
| $1.58M | 0.13% |
11,850
-1,950
| -14% | -$260K |
|
|
PTLA
99
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $1.57M | 0.13% |
41,500
-1,200
| -3% | -$45.3K |
|
100
Insulet
PODD
$24.2B
| $1.54M | 0.13% |
18,000
| – | – |
|